Calculus View on UK Industrial Strategy

The Prime Minister delivered a speech this week outlining the Government’s Industrial Strategy which aims to tackle the ‘Four Grand Challenges’ facing the world today, along with a target that UK R&D spend reaches 2.4% of GDP by 2027. The … Continued

Meet the CEO – Weedingtech

Following the recent CEO seminar featuring Calculus Capital portfolio company, Weedingtech, we are pleased to present the following video providing an overview of the company from Weedingtech CEO, Leo de Montaignac, and Calculus Capital Investment Director, Alexander Crawford.Weedingtech are the … Continued

Synpromics Awarded £1.9m Grant from Scottish Enterprise

Synpromics has announced it has been awarded a £1.9 million research and development grant from Scottish Enterprise. The funds will expand Synpromics’ world leading R&D programmes in gene regulation for cell and gene medicines. This grant is part of Synpromics’ ambitious … Continued

Calculus completes a further investment in Mologic

Calculus Capital has completed a further investment into a growth capital investment round for Mologic alongside Foresight Group, who led the round. Mologic is a Point of Care (POC) diagnostics company that provides Contract Research (CRO) and manufacturing (CMO) services. … Continued

ActiveOps – Delivering Growth

Calculus portfolio company ActiveOps provides best in class solutions to organisations looking to optimise the use of their technical and human resources. Since Calculus invested in March 2014, the Company has grown significantly. Total revenues have grown by over 130%, … Continued

Synpromics awarded Innovate UK grant

Calculus portfolio company, Synpromics, has announced a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made possible through the award of a £235,000 grant, part of … Continued

Calculus completes two further investments

On 29 March, Calculus completed two follow-on investments into portfolio companies Weedingtech and Quai. These investments represent further funding and support for businesses we have previously backed as they continue to grow. Weedingtech is a multi-award winning cleantech company and … Continued

C4X CEO discusses landmark Indivior deal

Clive Dix, Chief Executive of C4X Discovery Holdings plc (LON:C4XD), discusses with Proactive’s Andrew Scott their licensing deal with FTSE 250-listed Indivior for its addiction behaviour suppressant, C4X3256. It is the first major partnership for C4X, which will receive US$10mn up front and a … Continued